Novartis India informs about integrated filing

28 Oct 2025 Evaluate

Pursuant to Regulation 10(1A) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SEBI Circular No. SEBI/HO/CFD/CFD-PoD2/CIR/P/2024/185 dated December 31 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 02, 2025, Novartis India has submitted the Unaudited Financial Statements for the Quarter and half year ended September 30, 2025 along with the Limited Review Report (Annexure I & II) and other disclosures as required under the Integrated Filing (Financial) for the quarter and half-year ended September 30, 2025.

The above information is a part of company’s filings submitted to BSE.  

Novartis Share Price

782.40 -17.65 (-2.21%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 269.20
Adani Enterprises 2171.45
Amrapali Industries 15.02
Rashi Peripheral 368.80
PDS 350.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×